Lymphopenia predicts infectious complications after alemtuzumab therapy in multiple sclerosis: Real-world experience from a Brazilian cohort. Tejo A M, Silva G D, de Holanda A C, Adoni T, Pereira S L A, Callegaro D, Tonacio A C Clin Neurol Neurosurg. 2026 Sep; 268:109497. PMID: 42173025. Abstract CommentRecommendBookmarkWatch